Carl Firth is the founder of ASLAN Pharmaceuticals. ASLAN Pharmaceuticals has raised $300M in total funding. Latest round: IPO. Based in Singapore.
Carl Firth is the CEO and founder of ASLAN Pharmaceuticals, a NASDAQ-listed clinical stage biotech, which he took public in 2018 and raised over $300M from leading global investors. Prior to founding ASLAN, Carl was Head of Asia Healthcare at Bank of America Merrill Lynch. Before joining the banking industry, he worked for AstraZeneca across various commercial and R&D roles.
Full founder directory · Investor directory · Company funding database · Fundraising library